Xuelian Tang Selected Research

Xuelian Tang Research Topics

4	Brain Injuries (Brain Injury) 12/2021 - 01/2017
3	Colitis 01/2023 - 01/2021
3	Stroke (Strokes) 12/2021 - 01/2017
3	Ischemic Stroke 10/2020 - 01/2017
3	Neoplasm Metastasis (Metastasis) 06/2018 - 11/2006
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2021
2	Adenocarcinoma of Lung 06/2018 - 01/2017
2	Ischemia 06/2018 - 04/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017 - 01/2017
1	Brain Infarction 12/2021
1	Colonic Neoplasms (Colon Cancer) 02/2021
1	Neuroblastoma 07/2018
1	Reperfusion Injury 07/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017
1	Cerebral Infarction 01/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2012
1	Cholangiocarcinoma 04/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2009
1	Neoplasms (Cancer) 11/2006
1	Lewis Lung Carcinoma 11/2006

3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2017
2	E-SelectinIBA 12/2021 - 01/2017
2	Dextran SulfateIBA 03/2021 - 01/2021
2	CytokinesIBA 01/2021 - 11/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2020 - 06/2018
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2020 - 04/2018
2	Oxygen (Dioxygen)IBA 07/2018 - 06/2018
2	Glucose (Dextrose)FDA LinkGeneric 07/2018 - 06/2018
2	Long Noncoding RNAIBA 06/2018 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2017
1	CD146 AntigenIBA 01/2023
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2023
1	P-SelectinIBA 12/2021
1	CXA-10IBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 03/2021
1	Sincalide FDA Link 02/2021
1	FucoseIBA 02/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2020
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2020
1	LX009IBA 07/2018
1	phenolic acidIBA 07/2018
1	AcidsIBA 07/2018
1	Neuroprotective AgentsIBA 07/2018
1	AfatinibIBA 04/2017
1	Tyrosine Kinase InhibitorsIBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	AntagomirsIBA 01/2017
1	lobaplatinIBA 04/2012
1	Polysaccharides (Glycans)IBA 11/2006

3	Therapeutics 02/2021 - 04/2018
1	Intravenous Administration 12/2021
1	Lasers (Laser) 05/2012